1. Home
  2. BYSI vs APT Comparison

BYSI vs APT Comparison

Compare BYSI & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYSI
  • APT
  • Stock Information
  • Founded
  • BYSI 2010
  • APT 1983
  • Country
  • BYSI United States
  • APT Canada
  • Employees
  • BYSI N/A
  • APT N/A
  • Industry
  • BYSI Biotechnology: Pharmaceutical Preparations
  • APT
  • Sector
  • BYSI Health Care
  • APT
  • Exchange
  • BYSI Nasdaq
  • APT Nasdaq
  • Market Cap
  • BYSI 72.1M
  • APT 61.6M
  • IPO Year
  • BYSI 2017
  • APT 1995
  • Fundamental
  • Price
  • BYSI $1.68
  • APT $4.68
  • Analyst Decision
  • BYSI
  • APT
  • Analyst Count
  • BYSI 0
  • APT 0
  • Target Price
  • BYSI N/A
  • APT N/A
  • AVG Volume (30 Days)
  • BYSI 32.9K
  • APT 13.1K
  • Earning Date
  • BYSI 04-14-2022
  • APT 05-08-2025
  • Dividend Yield
  • BYSI N/A
  • APT N/A
  • EPS Growth
  • BYSI N/A
  • APT 2.28
  • EPS
  • BYSI N/A
  • APT 0.36
  • Revenue
  • BYSI N/A
  • APT $58,180,000.00
  • Revenue This Year
  • BYSI N/A
  • APT N/A
  • Revenue Next Year
  • BYSI N/A
  • APT N/A
  • P/E Ratio
  • BYSI N/A
  • APT $12.87
  • Revenue Growth
  • BYSI N/A
  • APT N/A
  • 52 Week Low
  • BYSI $0.98
  • APT $4.06
  • 52 Week High
  • BYSI $3.63
  • APT $6.44
  • Technical
  • Relative Strength Index (RSI)
  • BYSI 52.97
  • APT 57.72
  • Support Level
  • BYSI $1.64
  • APT $4.38
  • Resistance Level
  • BYSI $2.14
  • APT $4.66
  • Average True Range (ATR)
  • BYSI 0.18
  • APT 0.14
  • MACD
  • BYSI 0.03
  • APT 0.06
  • Stochastic Oscillator
  • BYSI 44.58
  • APT 97.73

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.

About APT Alpha Pro Tech Ltd.

Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.

Share on Social Networks: